openPR Logo
Press release

Continuous Glucose Monitoring (CGM) Devices Market estimated to be valued at US$ 820.1 million in 2017 and will going to hit Industry with CAGR of 13.3% by 2023

10-09-2018 04:51 PM CET | Health & Medicine

Press release from: Optima Insights Pvt. Ltd.

Continuous Glucose Monitoring (CGM) Devices Market estimated

Optima Insights bring out a New Market Research Report on –“Continuous Glucose Monitoring (CGM) Devices Market 2018 Analysis By Key Players – Medtronic, Dexcom, Inc., Abbott Laboratories, Senseonics

Description:-
This report focuses on the Continuous Glucose Monitoring (CGM) Devices status, future forecast, growth opportunity, key market and key players.

U.S. Continuous Glucose Monitoring (CGM) Devices Market Outlook Report to 2023.

According to Optima Insights, the U.S. continuous glucose monitoring (CGM) devices market is estimated to be valued at US$ 820.1 million in 2017 and is anticipated to exhibit a CAGR of 13.3% over the forecast period (2019 – 2023).

Key Trends and Analysis of the U.S. Continuous Glucose Monitoring (CGM) Devices Market:

Increasing pipeline products and favorable reimbursement policies by Center for Medicare & Medicaid Services (CMS) to strengthen the U.S. Continuous Glucose Monitoring Devices market, over the forecast period. For instance, companies such as Biorasis, Inc, Nemaura Medical, Sano Intelligence Inc., Verily Lifesciences, etc are a few of the emerging companies which are projected to flourish the U.S. Continuous Glucose Monitoring market, in a short span on 1 to 2 years. Additionally, there are players with promising disruptive technology in Continuous Glucose Monitoring to outstand the current CGM devices in the market.

Moreover, The U.S. diabetes population is one of the major factors leading to the growth on U.S. Continuous Glucose Monitoring Systems. For instance, according to the Centers for Disease Control and Prevention (CDC) & National Diabetes Statistics Reports, 2017, in 2015, diabetes was the seventh leading cause of death in the U.S. which was based on 79,535 death certificates in which diabetes was denoted as the underlying cause of death

According to Center for Disease Control and Prevention (CDC), 2015, 30.3 Mn Americans, 9.4% of the U.S. population have diabetes. The other 84.1 Mn have prediabetes, a condition that if not treated often leads to type 2 diabetes within five years.

Feel Free to Send us Inquiry, Our experts will guide you @ https://www.optimainsights.org/categories/diabetic-devices

Key Market Takeaways:

• The U.S. continuous glucose monitoring (CGM) devices market is estimated to exhibit a CAGR of 13.3% during the forecast period (2019 – 2023), attributed to the integration of CGM data with insulin pump systems is now allowing some early forays into the automation of basal insulin infusion rates to reduce the risk of hypoglycemia. The recent is FDA authorized CGM product is Dexcom’s G6
• Market growth has been observed due to the edge on,by continuous glucose monitoring devices over traditional glucose monitoring devices with ease real-time glucose measurements, paving way toreduced chronic type II diabetes complications such as averting episodes of hypoglycemia causing reduced overall diabetes care costs and also improving quality of life for the patients
• Key market players operating in the U.S. Continuous Glucose Monitoring (CGM) devices market includes Medtronic, Abbott Laboratories, Dexcom, Senseonics., etc…

Optima Insights has a geographical/regional coverage on five major regions, including, North America, Latin America, Europe, Asia Pacific,and Middle East & Africa. This extensive regional coverage also deep dives into major 26 countries, includes, U.S., Mexico, Argentina, Canada, Brazil, Rest of Latin America, U.K., Germany, France, Italy, Spain, Russia and Rest of Europe, India, China, Japan, Australia, South Korea, Australia, ASEAN, Rest of Asia Pacific, GCC, Rest of Middle East, Israel, North Africa, Central Africa and South Africa.

For more details please log on to: https://www.optimainsights.org

About Optima Insights:

Optima Insights is an innovative research and insights driven enterprise committed to offer actionable intelligence to the global life science and healthcare market players. We believe that meaningful insights and improved strategic content holds the key to improved ROI for our clients. We strike an innovative engagement model with our clients to Co-Create Intelligence that would address very specific issues facing them within their functional areasto develop targeted research solutions at compelling price point. We continuously support clients through the entire journey map to enable them take better business decisions towards attaining market leadership.

Contact:

Chucks G
Dir-Global Sales & BD
Mobile: +1 4242554365
chucksg@optimainsights.org
www.optimainsights.org

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Continuous Glucose Monitoring (CGM) Devices Market estimated to be valued at US$ 820.1 million in 2017 and will going to hit Industry with CAGR of 13.3% by 2023 here

News-ID: 1291383 • Views:

More Releases from Optima Insights Pvt. Ltd.

Sickle Cell Anemia Therapeutics Market to Witness a Pronounce Growth During 2026
Sickle Cell Anemia Therapeutics Market to Witness a Pronounce Growth During 2026
The Sickle Cell Anemia Treatment Market was valued at US$2.26 billion in the year 2018 and is estimated to reach US$6.46 billion by 2026, at a CAGR of 14.05%. Sickle Cell Anemia is an autosomal recessive disorder caused by a mutation in the hemoglobin-β gene found on chromosome 11, due to which the red blood cells become sickle or crescent moon shaped and get stuck in small blood vessels. This can
Market Research Report on Global Orthotic Devices Market Outlook to 2026
Market Research Report on Global Orthotic Devices Market Outlook to 2026
Orthotics can be characterized as the brace, support or splint used to align, prevent, support or to address the working of versatile body parts, for example, knee, wrist, shoulder, neck and so on. The medical field which manages the design and assembling of these devices is known as Orthotics. The orthotic devices are fundamentally used to defeat from the disabling illness, congenital condition or traumatic injury. The Overall Global Orthotic
Neurodegenerative Disease Market Trends, Opportunities and Challenges in 2026
Neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration and/or death of nerve cells. This causes problems with movement (Ataxia), or mental functioning (dementia). The overall Global Neurodegenerative Disease Market is expected to grow at a significant compound CAGR rate of 6.8% from USD 32.65 billion in 2018 to USD 55.26 billion in 2026. This expansion in neurodegenerative disease is due to the ascending public awareness and
Global Breast Cancer Treatment Market Expected to Reach $45.52 bn by 2026
Global Breast Cancer Treatment Market Expected to Reach $45.52 bn by 2026
The incidence of breast cancer is higher in urban areas, especially the metropolitan cities where it is now the leading female cancer and is the second most common cancer after cervix in rural and semi-urban areas. As for other cancers, late-stage presentation is also a common scenario for breast cancer. The overall Global Breast Cancer Treatment Market is expected to grow at a significant compound CAGR rate of 12.9% from

All 5 Releases


More Releases for CGM

Universal Adhesive Patch For CGM And Insulin Pump
Universal adhesive patch for CGM and insulin pump, waterproof breathable transparent patch, pre-cut tape, CGM protection, skin-friendly patch for 10-14 days Waterproof & Reinforced Defense - Pair it with your CGM Blood Glucose Monitoring Sensor [https://www.uwtapes.com/uw-adhesive-patch/] or TruSteel Infusion Kit while showering, bathing, exercising or swimming without worry. Protect your CGM sensor from collisions. Compatible with CGM sensors and insulin pumps [https://www.uwtapes.com/uw-adhesive-patch/] - ideal for users of closed loop systems. Suitable for
Global BGM and CGM Market Research Report 2023-2029
Blood glucose monitoring is the use of a glucose meter for testing the concentration of glucose in the blood. Particularly important in diabetes management, a blood glucose test is typically performed by piercing the skin (typically, on the finger) to draw blood, then applying the blood to a chemically active disposable 'test-strip'. The test is usually referred to as capillary blood glucose. Continuous glucose monitoring automatically tracks blood glucose levels,
Continuous Glucose Monitoring (CGM) Devices Market Higher convenience offered by …
The CGM displays a glucose trend graph and direction arrows allowing people with diabetes to anticipate approaching glucose highs and lows, thus alerting the wearer during distracted times like playing, sleeping or exercising. The CGM devices market is expected to gain a significant traction in Asia Pacific owing to the collaborations between endocrinologists, credentialed diabetes educators and stakeholder organizations for diabetes prevention. In 2017, National Diabetes Services Scheme (NDSS) initiated by
Global Continuous Glucose Monitoring Devices (CGM) Market
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Continuous Glucose Monitoring Device Market. The report analyzes the Global Continuous Glucose Monitoring Market by Component (Transmitter & receiver, sensor, Integrated Insulin Pump), By Demographics (Pediatric, Adult), By End user (Homecare, Hospital), By Region (North America, Europe, Asia Pacific, Rest of the world)
CMA CGM S. A. - Company Strategy & Performance Analysis
The research report presents a comprehensive assessment of the CMA CGM S. A. and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and deal landscapes. Purchase the Report at (USD $499 only): https://www.marketinsightsreports.com/report/purchase/0926871550?mode=su?source=openpr&Mode=12                   CMA CGM
Global Continuous Glucose Monitoring (CGM) Market,
The Global Continuous Glucose Monitoring Market (CGM) was valued at US$ 444.0 million in 2015 and is projected to reach US$ 1,025.2 million by 2024, according to a new report by published by Coherent Market Insights. CGM devices allow monitoring of glucose level during bedtime, noon, pre/post lunch, or before/after exercise, which is a major factor propelling growth of the continuous glucose monitoring market. The global CGM market is undergoing a